Teachers Advisors’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History

Teachers Advisors’s Portfolio BLCM Stock Details BLCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$502K	Buy	14,884 +72	+0.5%	+$2.41K	﹤0.01%	2536
2018 Q4	$432K	Buy	14,812 +1,687	+13%	+$74.8K	﹤0.01%	2571
2018 Q3	$808K	Buy	13,125 +46	+0.4%	+$3.11K	﹤0.01%	2422
2018 Q2	$965K	Buy	13,079 +4,663	+55%	+$363K	﹤0.01%	2340
2018 Q1	$552K	Buy	8,416 +24	+0.3%	+$1.81K	﹤0.01%	2491
2017 Q4	$706K	Buy	8,392 +104	+1%	+$10.2K	﹤0.01%	2406
2017 Q3	$957K	Buy	8,288 +341	+4%	+$35.9K	﹤0.01%	2255
2017 Q2	$928K	Buy	7,947 +4,372	+122%	+$543K	﹤0.01%	2270
2017 Q1	$441K	Buy	3,575 +14	+0.4%	+$1.83K	﹤0.01%	2598
2016 Q4	$485K	Buy	3,561 +185	+5%	+$32.8K	﹤0.01%	2558
2016 Q3	$672K	Hold	3,376	–	–	﹤0.01%	2309
2016 Q2	$438K	Buy	3,376 +2,161	+178%	+$241K	﹤0.01%	2492
2016 Q1	$114K	Hold	1,215	–	–	﹤0.01%	2924
2015 Q4	$246K	Hold	1,215	–	–	﹤0.01%	2792
2015 Q3	$177K	Hold	1,215	–	–	﹤0.01%	2915
2015 Q2	$258K	Buy	1,215 +390	+47%	+$95.6K	﹤0.01%	2900
2015 Q1	$191K	Buy	+825	New	+$200K	﹤0.01%	2898

Other funds holding BLCM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Teachers Advisors's BLCM Position: Q1 2019 in Review

Teachers Advisors increased its Bellicum Pharmaceuticals, Inc. (BLCM) stake by 0.49% in Q1 2019, buying an estimated $2.41K and bringing the position to 14,884 shares worth $502K. The position accounts for ﹤0.01% of the portfolio, ranked #2536.

Teachers Advisors first reported a position in BLCM in Q1 2015 and has held it in 17 quarters since. The position peaked at $965K in Q2 2018. 94 funds tracked by Wall St. Rank hold BLCM as of Q1 2019.

Teachers Advisors held 14,884 shares of Bellicum Pharmaceuticals, Inc. worth $502K as of Q1 2019.
Teachers Advisors bought 72 Bellicum Pharmaceuticals, Inc. shares in Q1 2019, an estimated $2.41K.
Bellicum Pharmaceuticals, Inc. made up ﹤0.01% of Teachers Advisors's portfolio in Q1 2019, its #2536 holding.
Teachers Advisors first reported a position in Bellicum Pharmaceuticals, Inc. in Q1 2015 and has held it in 17 quarters since.
Teachers Advisors's Bellicum Pharmaceuticals, Inc. position peaked at $965K in Q2 2018.
94 funds tracked by Wall St. Rank held Bellicum Pharmaceuticals, Inc. as of Q1 2019.

Based on Teachers Advisors's 13F filing for Q1 2019, filed 14 May 2019.